HJ Research delivers in-depth insights on the global Cancer Therapies market in its upcoming report titled, Global Cancer Therapies Market Report 2018-2029. According to this study, the global Cancer Therapies market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Cancer Therapies market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Cancer Therapies market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Cancer Therapies industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Cancer Therapies industry.
Global Cancer Therapies market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Cancer Therapies industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Cancer Therapies market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Cancer Therapies. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Cancer Therapies market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Cancer Therapies in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Cancer Therapies market include:
Amgen
AstraZeneca
Bristol-Myers Squibb
Bayer AG
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Market segmentation, by product types:
Immunological and Vaccine Approaches
Antiproliferative Approaches
Photodynamic Therapy
Gene Therapy Approaches
Cell Cycle and Apoptosis Approaches
Market segmentation, by applications:
Hospital Use
Clinic Use
Household
Other
1 Industry Overview of Cancer Therapies
1.1 Research Scope
1.2 Market Segmentation by Types of Cancer Therapies
1.3 Market Segmentation by End Users of Cancer Therapies
1.4 Market Dynamics Analysis of Cancer Therapies
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Cancer Therapies Industry
2.1 Amgen
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Cancer Therapies Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 AstraZeneca
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Cancer Therapies Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Bristol-Myers Squibb
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Cancer Therapies Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Bayer AG
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Cancer Therapies Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 F. Hoffmann-La Roche Ltd
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Cancer Therapies Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 GlaxoSmithKline PLC
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Cancer Therapies Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Johnson & Johnson
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Cancer Therapies Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Merck & Co. Inc.
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Cancer Therapies Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Novartis AG
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Cancer Therapies Revenue and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 Pfizer Inc.
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Cancer Therapies Revenue and Gross Margin (2018-2023)
2.10.4 Contact Information
3 Global Cancer Therapies Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Cancer Therapies by Regions (2018-2023)
3.2 Global Sales Revenue of Cancer Therapies by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Cancer Therapies by Types (2018-2023)
3.4 Global Sales Revenue of Cancer Therapies by End Users (2018-2023)
4 Northern America Cancer Therapies Market Analysis by Countries, Types and End Users
4.1 Northern America Cancer Therapies Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Cancer Therapies Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Cancer Therapies Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Cancer Therapies Sales Revenue Analysis (2018-2023)
4.5 Canada Cancer Therapies Sales Revenue Analysis (2018-2023)
5 Europe Cancer Therapies Market Analysis by Countries, Types and End Users
5.1 Europe Cancer Therapies Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Cancer Therapies Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Cancer Therapies Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Cancer Therapies Sales Revenue Analysis (2018-2023)
5.5 France Cancer Therapies Sales Revenue Analysis (2018-2023)
5.6 UK Cancer Therapies Sales Revenue Analysis (2018-2023)
5.7 Italy Cancer Therapies Sales Revenue Analysis (2018-2023)
5.8 Russia Cancer Therapies Sales Revenue Analysis (2018-2023)
5.9 Spain Cancer Therapies Sales Revenue Analysis (2018-2023)
5.10 Netherlands Cancer Therapies Sales Revenue Analysis (2018-2023)
6 Asia Pacific Cancer Therapies Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Cancer Therapies Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Cancer Therapies Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Cancer Therapies Sales Revenue Analysis by End Users (2018-2023)
6.4 China Cancer Therapies Sales Revenue Analysis (2018-2023)
6.5 Japan Cancer Therapies Sales Revenue Analysis (2018-2023)
6.6 Korea Cancer Therapies Sales Revenue Analysis (2018-2023)
6.7 India Cancer Therapies Sales Revenue Analysis (2018-2023)
6.8 Australia Cancer Therapies Sales Revenue Analysis (2018-2023)
6.9 Indonesia Cancer Therapies Sales Revenue Analysis (2018-2023)
6.10 Vietnam Cancer Therapies Sales Revenue Analysis (2018-2023)
7 Latin America Cancer Therapies Market Analysis by Countries, Types and End Users
7.1 Latin America Cancer Therapies Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Cancer Therapies Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Cancer Therapies Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Cancer Therapies Sales Revenue Analysis (2018-2023)
7.5 Mexico Cancer Therapies Sales Revenue Analysis (2018-2023)
7.6 Argentina Cancer Therapies Sales Revenue Analysis (2018-2023)
7.7 Colombia Cancer Therapies Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Cancer Therapies Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Cancer Therapies Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Cancer Therapies Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Cancer Therapies Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Cancer Therapies Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Cancer Therapies Sales Revenue Analysis (2018-2023)
8.6 South Africa Cancer Therapies Sales Revenue Analysis (2018-2023)
8.7 Egypt Cancer Therapies Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Cancer Therapies Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Cancer Therapies by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Cancer Therapies by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Cancer Therapies by End Users (2024-2029)
10.4 Global Revenue Forecast of Cancer Therapies by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Cancer Therapies
11.1 Upstream Analysis of Cancer Therapies
11.2 Downstream Major Consumers Analysis of Cancer Therapies
11.3 Major Suppliers of Cancer Therapies with Contact Information
11.4 Supply Chain Relationship Analysis of Cancer Therapies
12 Cancer Therapies New Project Investment Feasibility Analysis
12.1 Cancer Therapies New Project SWOT Analysis
12.2 Cancer Therapies New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Cancer Therapies Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Cancer Therapies
Table End Users of Cancer Therapies
Figure Market Drivers Analysis of Cancer Therapies
Figure Market Challenges Analysis of Cancer Therapies
Figure Market Opportunities Analysis of Cancer Therapies
Table Market Drivers Analysis of Cancer Therapies
Table Amgen Information List
Figure Cancer Therapies Specifications of Amgen
Table Cancer Therapies Revenue (Million USD) and Gross Margin of Amgen (2018-2023)
Figure Cancer Therapies Revenue (Million USD) and Global Market Share of Amgen (2018-2023)
Table AstraZeneca Information List
Figure Cancer Therapies Specifications of AstraZeneca
Table Cancer Therapies Revenue (Million USD) and Gross Margin of AstraZeneca (2018-2023)
Figure Cancer Therapies Revenue (Million USD) and Global Market Share of AstraZeneca (2018-2023)
Table Bristol-Myers Squibb Information List
Figure Cancer Therapies Specifications of Bristol-Myers Squibb
Table Cancer Therapies Revenue (Million USD) and Gross Margin of Bristol-Myers Squibb (2018-2023)
Figure Cancer Therapies Revenue (Million USD) and Global Market Share of Bristol-Myers Squibb (2018-2023)
Table Bayer AG Information List
Figure Cancer Therapies Specifications of Bayer AG
Table Cancer Therapies Revenue (Million USD) and Gross Margin of Bayer AG (2018-2023)
Figure Cancer Therapies Revenue (Million USD) and Global Market Share of Bayer AG (2018-2023)
Table F. Hoffmann-La Roche Ltd Information List
Figure Cancer Therapies Specifications of F. Hoffmann-La Roche Ltd
Table Cancer Therapies Revenue (Million USD) and Gross Margin of F. Hoffmann-La Roche Ltd (2018-2023)
Figure Cancer Therapies Revenue (Million USD) and Global Market Share of F. Hoffmann-La Roche Ltd (2018-2023)
Table GlaxoSmithKline PLC Information List
Figure Cancer Therapies Specifications of GlaxoSmithKline PLC
Table Cancer Therapies Revenue (Million USD) and Gross Margin of GlaxoSmithKline PLC (2018-2023)
Figure Cancer Therapies Revenue (Million USD) and Global Market Share of GlaxoSmithKline PLC (2018-2023)
Table Johnson & Johnson Information List
Figure Cancer Therapies Specifications of Johnson & Johnson
Table Cancer Therapies Revenue (Million USD) and Gross Margin of Johnson & Johnson (2018-2023)
Figure Cancer Therapies Revenue (Million USD) and Global Market Share of Johnson & Johnson (2018-2023)
Table Merck & Co. Inc. Information List
Figure Cancer Therapies Specifications of Merck & Co. Inc.
Table Cancer Therapies Revenue (Million USD) and Gross Margin of Merck & Co. Inc. (2018-2023)
Figure Cancer Therapies Revenue (Million USD) and Global Market Share of Merck & Co. Inc. (2018-2023)
Table Novartis AG Information List
Figure Cancer Therapies Specifications of Novartis AG
Table Cancer Therapies Revenue (Million USD) and Gross Margin of Novartis AG (2018-2023)
Figure Cancer Therapies Revenue (Million USD) and Global Market Share of Novartis AG (2018-2023)
Table Pfizer Inc. Information List
Figure Cancer Therapies Specifications of Pfizer Inc.
Table Cancer Therapies Revenue (Million USD) and Gross Margin of Pfizer Inc. (2018-2023)
Figure Cancer Therapies Revenue (Million USD) and Global Market Share of Pfizer Inc. (2018-2023)
Table Global Revenue (Million USD) of Cancer Therapies by Regions (2018-2023)
Table Global Revenue (Million USD) of Cancer Therapies by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Cancer Therapies by Types (2018-2023)
Table Global Revenue (Million USD) of Cancer Therapies by End Users (2018-2023)
Table Northern America Cancer Therapies Revenue (Million USD) by Countries (2018-2023)
Table Northern America Cancer Therapies Revenue (Million USD) by Types (2018-2023)
Table Northern America Cancer Therapies Revenue (Million USD) by End Users (2018-2023)
Figure United States Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Cancer Therapies Revenue (Million USD) by Countries (2018-2023)
Table Europe Cancer Therapies Revenue (Million USD) by Types (2018-2023)
Table Europe Cancer Therapies Revenue (Million USD) by End Users (2018-2023)
Figure Germany Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Cancer Therapies Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Cancer Therapies Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Cancer Therapies Revenue (Million USD) by End Users (2018-2023)
Figure China Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Cancer Therapies Revenue (Million USD) by Countries (2018-2023)
Table Latin America Cancer Therapies Revenue (Million USD) by Types (2018-2023)
Table Latin America Cancer Therapies Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Cancer Therapies Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Cancer Therapies Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Cancer Therapies Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Cancer Therapies Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Cancer Therapies by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Cancer Therapies by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Cancer Therapies by End Users (2024-2029)
Table Major Consumers with Contact Information of Cancer Therapies
Table Major Suppliers of Cancer Therapies with Contact Information
Figure Supply Chain Relationship Analysis of Cancer Therapies
Table New Project SWOT Analysis of Cancer Therapies
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Cancer Therapies
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Cancer Therapies Industry
Table Part of References List of Cancer Therapies Industry
Table Units of Measurement List
Table Part of Author Details List of Cancer Therapies Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Cancer Therapies industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Cancer Therapies market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Cancer Therapies manufacturers, Cancer Therapies raw material suppliers, Cancer Therapies distributors as well as buyers. The primary sources from the supply side include Cancer Therapies manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Cancer Therapies raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Cancer Therapies industry landscape and trends, Cancer Therapies market dynamics and key issues, Cancer Therapies technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Cancer Therapies competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Cancer Therapies market size and forecast by regions, Cancer Therapies market size and forecast by application, Cancer Therapies market size and forecast by types, Cancer Therapies company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
